How many insider trades does FilingIQ track for CLDI?

FilingIQ tracks 33 Form 4 insider transactions for CLDI (Calidi Biotherapeutics, Inc.), covering filings from Sep 12, 2023 onwards. 8 of those were filed in the last 90 days.

Are CLDI insiders net buyers or net sellers?

Across the full Form 4 history for CLDI, 4 transactions (12%) were open-market purchases and 2 (6%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does CLDI insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is CLDI in?

Calidi Biotherapeutics, Inc. (CLDI) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $2.57M.

CLDI insider trading

NYSE American Healthcare

Calidi Biotherapeutics, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

Last 90 days

Buys / sells

12% / 6%

Market cap

$2.57M

About Calidi Biotherapeutics, Inc.

Calidi Biotherapeutics, Inc., a clinical stage immuno-oncology company, develops allogeneic stem cell-based and enveloped virus platforms to potentiate and deliver oncolytic viruses in the United States. Its product pipeline comprises CLD-101, which is in Phase 1b/2 clinical trial for the treatment of high-grade glioma, as well as in Phase 1 dose-escalation clinical trial for recurrent high-grade glioma; CLD-201 product for solid tumors, such as breast cancer, head and neck squamous cell carcinoma, and soft tissue sarcoma, which is in pre-clinical studies; CLD-301 for multiple indications, which is in preclinical studies; and CLD-400 for certain lung cancer and metastatic solid tumors. The company also offers oncolytic virus platforms, such as NeuroNova, SuperNova, and RTNova. Calidi Biotherapeutics, Inc. was founded in 2014 and is headquartered in San Diego, California.

Company website: www.calidibio.com

CLDI insider activity at a glance

FilingIQ has scored 33 insider transactions for CLDI since Sep 12, 2023. The most recent filing in our index is dated Aug 17, 2026.

Across the full history, 4 open-market purchases and 2 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on CLDI insider trades is 67.8/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live CLDI trades on FilingIQ Raw filings on SEC EDGAR

Latest CLDI Form 4 filings

Poma Eric E Chief Executive Officer

P Aug 21, 2025

Schoeneck James A

P Aug 21, 2025

Jackson Andrew C. Chief Financial Officer

P Aug 21, 2025

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

UTHR 983

UNITED THERAPEUTICS Corp

NUVL 195

Nuvalent, Inc.

KYMR 193

Kymera Therapeutics, Inc.

GH 192

Guardant Health, Inc.

Hims & Hers Health, Inc.

Frequently asked

How many insider trades does FilingIQ track for CLDI?: FilingIQ tracks 33 Form 4 insider transactions for CLDI (Calidi Biotherapeutics, Inc.), covering filings from Sep 12, 2023 onwards. 8 of those were filed in the last 90 days.
Are CLDI insiders net buyers or net sellers?: Across the full Form 4 history for CLDI, 4 transactions (12%) were open-market purchases and 2 (6%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does CLDI insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is CLDI in?: Calidi Biotherapeutics, Inc. (CLDI) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $2.57M.

Methodology & sources

Every CLDI insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.